MoneyWorks4Me

GlaxoSmithKline Pharmaceuticals board recommends dividend

16 Feb 2012 Evaluate

GlaxoSmithKline Pharmaceuticals has informed that the board of directors of the company at its meeting held on February 16, 2012, recommended a dividend of Rs 45 per equity share for the year ended December 31, 2011.

The above information is part of company’s filing submitted to the BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..